[ad_1]
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) — Guardion Well being Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Firm”), a specialty well being sciences firm that develops clinically supported vitamin, medical meals and medical gadgets, with a spotlight within the ocular well being market, at the moment declares the appointment of Bret Scholtes, a veteran of the dietary merchandise business for practically a decade, as its President and Chief Government Officer, and as a member of the Board of Administrators, commencing January 6, 2021.
“We’re delighted to welcome Bret to Guardion Well being Sciences. We consider that his confirmed enterprise acumen and in depth expertise within the dietary merchandise business will serve to usher Guardion into a brand new period of progress and success,” commented Robert Weingarten, Chairman of the Board of Guardion Well being Sciences. “Bret’s accomplishments as a pacesetter of a NYSE-listed dietary merchandise firm embody vital and sustained income and revenue progress, a profitable acquisition and integration technique, and finally a big liquidity occasion for its public stockholders. We consider that Bret’s expertise will present the instruments and management abilities that Guardion requires to develop and execute each near-term and longer-term enterprise methods centered on product and market improvement that may translate into income progress and finally profitability. We consider that these efforts will finally drive stockholder worth.”
Mr. Weingarten continued, “We’ve structured Bret’s compensation package deal in a manner that aligns his strategic focus with the first aim of our shareholders, which is to extend stockholder worth. The Board additionally thanks Dr. David Evans for his helpful stewardship whereas serving because the Firm’s interim President and Chief Government Officer throughout these extraordinary occasions.”
Mr. Scholtes has spent the final 9 years as CEO of Omega Protein Company (“Omega”), a world dietary merchandise firm which traded on the New York Inventory Alternate till it was efficiently offered to a strategic purchaser in late 2017. Omega operated branded and personal label ingredient companies with greater than 1,100 workers. Throughout his time at Omega, annualized revenues elevated by 55%, EBITDA grew by greater than 70%, and Omega’s inventory worth elevated by roughly 260%. As well as, Mr. Scholtes spearheaded the acquisition of 4 corporations, which added roughly $125 million to revenues by complementary product traces, launched greater than 40 new merchandise, and expanded efficiently into a number of new markets. Previous to his time at Omega, Mr. Scholtes served as Vice President, Origination at GE Power Monetary Companies, the place he co-originated acquisitions with a mixed enterprise worth of greater than $four billion. He has additionally held a number of company improvement and public accounting positions, together with durations at Worth Waterhouse and Arthur Andersen & Co. Mr. Scholtes holds a Grasp of Enterprise Administration diploma from New York College, a Bachelor of Science diploma in Accounting from the College of Missouri, and is a licensed public accountant.
Mr. Scholtes commented, “I used to be instantly interested in Guardion Well being Sciences for its scientifically-proven dietary merchandise and medical meals, mixed with a product line of evidence-based diagnostic applied sciences, which collectively present a chic mixture of merchandise and applied sciences that mirror what we now have seen in different therapy areas coated by the pharmaceutical and diagnostic areas. The present market setting presents a number of challenges, from acceptance of the science behind medical meals and dietary dietary supplements, to distribution points that emerged from the COVID-19 pandemic, to increasing our markets in Asia and different territories. Nonetheless, I’m assured that my expertise may help drive Guardion’s profitable implementation of its enterprise plans and aims based mostly on evidence-based protocols, and I sit up for working with Guardion’s administration group and administrators to drive present merchandise into the market and convey distinctive and compelling new merchandise to the market to assist the well being and well-being of its clients.”
About Guardion Well being Sciences
Guardion is a specialty well being sciences firm that develops clinically supported vitamin, medical meals and medical gadgets, with a spotlight within the ocular well being market. Positioned in San Diego, California, the Firm combines focused vitamin with revolutionary, evidence-based diagnostic know-how. Guardion boasts spectacular Scientific and Medical Advisory Boards. Data and threat components with respect to Guardion and its enterprise, together with its means to efficiently develop and commercialize its proprietary merchandise and applied sciences, could also be obtained within the Firm’s filings with the SEC at www.sec.gov.
Ahead-Trying Assertion Disclaimer
Except for the historic data contained on this information launch, the issues described herein could comprise forward-looking statements inside the which means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended. Statements preceded by, adopted by or that in any other case embody the phrases “believes,” “expects,” “anticipates,” “intends,” “initiatives,” “estimates,” “plans” and related expressions or future or conditional verbs corresponding to “will,” “ought to,” “would,” “could” and “may” are usually forward- wanting in nature and never historic info, though not all forward-looking statements embody the foregoing. These statements contain unknown dangers and uncertainties that will individually or materially influence the issues mentioned herein for quite a lot of causes which are outdoors the management of the Firm, together with, however aren’t restricted to, the Firm’s means to boost ample financing to implement its marketing strategy, the mixing of a brand new administration group, the influence of the COVID-19 pandemic on the Firm’s enterprise, operations and the economic system on the whole, and the Firm’s means to efficiently develop and commercialize its proprietary merchandise and applied sciences. Readers are cautioned to not place undue reliance on these forward- wanting statements, as precise outcomes may differ materially from these described within the forward-looking statements contained herein. Readers are urged to learn the chance components set forth within the Firm’s filings with the SEC, which can be found on the SEC’s web site (www.sec.gov). The Firm disclaims any intention or obligation to replace or revise any forward-looking statements, whether or not because of new data, future occasions or in any other case.
Investor Relations Contact:
CORE IR
Scott Arnold
516-222-2560
scotta@coreir.com
Media Relations Contact:
Jules Abraham
Director of Public Relations
CORE IR
917-885-7378
julesa@coreir.com
[ad_2]
Source link
